Table 2:
Model-specific and overall vaccine coverage of tetanus–diphtheria–acellular pertussis vaccine
| Vaccine delivery model | No. of vaccinated participants | No. (%) of vaccinated participants who were vaccinated within the model | Model-specific VC | Overall VC | |||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
||||||||
| No. (%) of participants vaccinated within the model (95% CI) | OR* (95% CI) | Adjusted OR† (95% CI) | Overall no. (%) of participants vaccinated (95% CI) | Absolute VC difference, % | OR* (95% CI) | Adjusted OR† (95% CI) | |||
| CLSC, n = 246 | 163 | 157 (96.3) | 157 (63.8) (57.6–69.6) | 1 (Ref.) | 1 (Ref.) | 163 (66.3) (60.1–71.9) | Ref. | 1 (Ref.) | 1 (Ref.) |
|
| |||||||||
| FMG, n = 171 | 148 | 116 (78.4) | 116 (67.8) (60.5–74.4) | 1.20 (0.79–1.81) | 1.26 (0.82–1.94) | 148 (86.5) (80.6–90.9) | 20.2 | 3.28 (1.99–5.57) | 4.05 (2.36–7.22) |
|
| |||||||||
| Obstetrics, n = 241 | 207 | 85 (41.1) | 85 (35.3) (29.5–41.5) | 0.31 (0.21–0.45) | 0.30 (0.20–0.44) | 207 (85.9) (80.9–89.7) | 19.6 | 3.10 (1.99–4.91) | 3.37 (2.11–5.49) |
|
| |||||||||
| OGCT, n = 288 | 178 | 127 (71.3) | 127 (44.1) (38.5–49.9) | 0.45 (0.31–0.63) | 0.47 (0.32–0.68) | 178 (61.8) (56.1–67.2) | 4.5 | 0.82 (0.58–1.17) | 0.92 (0.62–1.37) |
Note: CI = confidence interval, CLSC = local community service centre, FMG = family medicine group, OGCT = oral glucose challenge test, OR = odds ratio, Ref. = reference, VC = vaccine coverage.
*
Odds ratios calculated from univariate logistic regression.
†
Adjusted ORs calculated from multivariable logistic regression, adjusting for maternal age, country of birth (Canada v. other), education, language and the number of previous children.